Homebiotech

biotech

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026

biotech

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

Jim Cornall - April 30, 2026

biotech

Aragen launches India’s first women-led chemistry synthesis laboratory

Jim Cornall - April 30, 2026

biotech

Vaccine strategy induces broadly neutralising HIV antibodies

Jim Cornall - April 30, 2026

biotech

New Genmab data shows anti-tumour activity

Jim Cornall - October 21, 2025

biotech

Endpoints met at 12 months for eye treatment

Jim Cornall - October 21, 2025

biotech

Improved cough-detection tech for health monitoring

Jim Cornall - October 20, 2025

biotech

FDA approves lupus nephritis treatment

Jim Cornall - October 20, 2025

biotech

NLS Days winners announced

Jim Cornall - October 20, 2025

biotech

Base to Base biotech podcast 31: Exhilarating enzymes and super socks

Jim Cornall - October 17, 2025

biotech

New company to develop psoriasis monoclonal antibody

Jim Cornall - October 15, 2025

biotech

DNA nanospring could boost disease diagnosis

Jim Cornall - October 15, 2025

1...414243...73 Page 42 of 73

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026 0

This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about...

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

biotech Jim Cornall - April 30, 2026 0

Aragen launches India’s first women-led chemistry synthesis laboratory

biotech Jim Cornall - April 30, 2026 0

Vaccine strategy induces broadly neutralising HIV antibodies

biotech Jim Cornall - April 30, 2026 0

New target for cancer treatment

biotech Jim Cornall - April 29, 2026 0